and/or refractory angina with respect to 'real-life' drug side effects and toxicity, therapeutic drug level monitoring, 5 year mortality outcomes and predictors of response to perhexiline therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback